相似文献
1
Targeting H3K4 trimethylation in Huntington disease.
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E3027-36. doi: 10.1073/pnas.1311323110. Epub 2013 Jul 19.
2
The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases.
Cell. 2007 Mar 23;128(6):1077-88. doi: 10.1016/j.cell.2007.02.017. Epub 2007 Feb 22.
3
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
Oncogene. 2012 Feb 9;31(6):776-86. doi: 10.1038/onc.2011.266. Epub 2011 Jul 4.
4
PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Cell Cycle. 2015;14(11):1716-29. doi: 10.1080/15384101.2015.1033595.
5
The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation.
Nature. 2007 May 31;447(7144):601-5. doi: 10.1038/nature05823. Epub 2007 Apr 29.
6
Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease.
Hum Mol Genet. 2018 Feb 15;27(4):649-666. doi: 10.1093/hmg/ddx432.
7
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
Eur J Neurosci. 2006 Feb;23(3):649-58. doi: 10.1111/j.1460-9568.2006.04590.x.
8
Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function.
Cell Rep. 2013 Apr 25;3(4):1071-9. doi: 10.1016/j.celrep.2013.02.030. Epub 2013 Mar 28.
9
Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation.
J Neurosci. 2008 Apr 9;28(15):3947-57. doi: 10.1523/JNEUROSCI.5667-07.2008.
10
Modulation of nucleosome dynamics in Huntington's disease.
Hum Mol Genet. 2007 May 15;16(10):1164-75. doi: 10.1093/hmg/ddm064. Epub 2007 Apr 2.
引用本文的文献
1
Inhibition of class IIa HDACs reduces mutant HTT aggregation by affecting RNA stability.
Front Mol Neurosci. 2025 Jun 18;18:1579194. doi: 10.3389/fnmol.2025.1579194. eCollection 2025.
2
Distinct molecular patterns in R6/2 HD mouse brain: Insights from spatiotemporal transcriptomics.
Neuron. 2025 Jun 6. doi: 10.1016/j.neuron.2025.05.014.
3
Accelerated epigenetic aging in Huntington's disease involves polycomb repressive complex 1.
Nat Commun. 2025 Feb 11;16(1):1550. doi: 10.1038/s41467-025-56722-z.
4
G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials.
Med Res Rev. 2025 May;45(3):985-1015. doi: 10.1002/med.22096. Epub 2025 Jan 6.
5
The Two Faces of HDAC3: Neuroinflammation in Disease and Neuroprotection in Recovery.
Epigenomics. 2024 Nov-Nov;16(21-22):1373-1388. doi: 10.1080/17501911.2024.2419357. Epub 2024 Nov 8.
6
Exploring the Frontier: Antisense Long Non-Coding RNAs as Key Regulators in Alzheimer's Disease.
Aging Dis. 2024 Aug 19;16(4):1793-1812. doi: 10.14336/AD.2024.0762.
7
Dysregulation of choline metabolism and therapeutic potential of citicoline in Huntington's disease.
Aging Cell. 2024 Nov;23(11):e14302. doi: 10.1111/acel.14302. Epub 2024 Aug 14.
8
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity.
Genes Dev. 2024 Jul 19;38(11-12):473-503. doi: 10.1101/gad.351444.123.
9
Neuroinflammation and the role of epigenetic-based therapies for Huntington's disease management: the new paradigm.
Inflammopharmacology. 2024 Jun;32(3):1791-1804. doi: 10.1007/s10787-024-01477-0. Epub 2024 Apr 23.
10
HD and SCA1: Tales from two 30-year journeys since gene discovery.
Neuron. 2023 Nov 15;111(22):3517-3530. doi: 10.1016/j.neuron.2023.09.036. Epub 2023 Oct 19.
本文引用的文献
1
Extensive changes in DNA methylation are associated with expression of mutant huntingtin.
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2354-9. doi: 10.1073/pnas.1221292110. Epub 2013 Jan 22.
2
Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues.
Nat Genet. 2012 Nov;44(11):1207-14. doi: 10.1038/ng.2442. Epub 2012 Oct 14.
3
H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sites.
Genome Med. 2012 May 28;4(5):47. doi: 10.1186/gm346.
4
Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons.
Arch Gen Psychiatry. 2012 Mar;69(3):314-24. doi: 10.1001/archgenpsychiatry.2011.151. Epub 2011 Nov 7.
5
Identifying polyglutamine protein species in situ that best predict neurodegeneration.
Nat Chem Biol. 2011 Oct 30;7(12):925-34. doi: 10.1038/nchembio.694.
6
What have we learned from gene expression profiles in Huntington's disease?
Neurobiol Dis. 2012 Jan;45(1):83-98. doi: 10.1016/j.nbd.2011.07.001. Epub 2011 Jul 12.
7
Genome-wide analysis of the relationships between DNaseI HS, histone modifications and gene expression reveals distinct modes of chromatin domains.
Nucleic Acids Res. 2011 Sep 1;39(17):7428-43. doi: 10.1093/nar/gkr443. Epub 2011 Jun 17.
8
ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity.
Nucleic Acids Res. 2011 Sep 1;39(17):7415-27. doi: 10.1093/nar/gkr416. Epub 2011 Jun 7.
9
Cell type-specific DNA methylation at intragenic CpG islands in the immune system.
Genome Res. 2011 Jul;21(7):1074-86. doi: 10.1101/gr.118703.110. Epub 2011 May 31.
10
Aligning short sequencing reads with Bowtie.
Curr Protoc Bioinformatics. 2010 Dec;Chapter 11:Unit 11.7. doi: 10.1002/0471250953.bi1107s32.
Zotero 插件